Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyModa Health Clinical Trials Coverage | OpenPayer
    Ask Trek AI about this page
    ModifiedModa HealthPolicy N/A

    Clinical Trials

    Customize your policy alerts

    Sign up for all Moda Health policy alerts

    Know when Moda Health releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines qualified clinical trials and coverage of routine patient care and related services for Moda Health members, with requirements varying by state and additional federal and prior authorization requirements.

    Policy Summary
    PayerModa Health
    PolicyClinical Trials
    Policy CodePolicy N/A
    Change TypeModified
    Effective DateOct 1, 2026
    Last ReviewSep 23, 2026
    Next Review DateN/A
    Key ActionSubmit prior authorization with the patient's history and physical, treatment history, detailed protocol, signed informed consent, and IRB approval.
    SourceLink
    POLICY UPDATE CHANGES

    The annual review history documents removal of codes S9992, S9994, and S9996 because the associated services were not covered.

    The policy history documents expanded indications for a non-covered drug or device in January 2020.

    The policy history documents additions of clinical-trial coverage guidelines for Texas and Idaho members and state-specific clinical-trial requirements.

    5 statesStates with specific coverage requirements
    4 phasesClinical trial phases recognized
    5 itemsPrior authorization documents required

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    7
    Covered HCPCS codes and modifiers
    1Covered diagnosis codes
    ExcludedResearch costs

    Qualified Clinical Trial Coverage Criteria

    State-specific qualified clinical trial requirements

    A clinical trial is qualified when the applicable state-specific requirements are met.

    State-specific qualification

    • Oregon: The trial is funded or supported by one or more of the following: NIH, including NCI; CDC; AHRQ; CMS; DOD; or VA, and it is conducted under an investigational new drug application, investigational device exemption, or biologics license application to the FDA, or is exempt by federal law from the requirement to submit an investigational new drug application.
    • Alaska: The trial is an approved scientific study involving human subjects designed to test or improve prevention, diagnosis, treatment, or palliative care of cancer, or to evaluate the safety and effectiveness of a drug, device, or procedure for prevention, diagnosis, treatment, or palliative care; and it is approved by an institutional review board that complies with 45 CFR Part 46 and by HHS, NIH or its institutes or centers, FDA, DOD, VA, or a nongovernmental research entity following current NIH guidelines.
    • Texas: The clinical trial is approved by CDC, NIH, FDA, DOD, VA, or an institutional review board of an institution in Texas that has an agreement with the HHS Office for Human Research Protections.
    • Idaho: The study is approved or funded, including through in-kind contributions, by NIH, CDC, AHRQ, CMS, a qualifying cooperative group or center through DOD or VA, or a qualified nongovernmental research entity identified in NIH center-support-grant guidelines; it is conducted under an FDA-reviewed investigational new drug application or is exempt from one; and it has been reviewed and approved by an institutional review board of an institution with an HHS Office for Human Research Protections agreement.
    • Washington: The trial meets Washington requirements for coverage of routine patient care costs, including compliance with trial-protocol eligibility requirements when required.

    Federal qualification and participant eligibility

    Under the federal criteria, coverage of patient care costs requires all qualification conditions and an appropriateness pathway.

    Federal qualified clinical trial

    • The trial is Phase I, II, III, or IV and concerns prevention, detection, or treatment of cancer or another life-threatening disease or condition.Phase I-IV
    • Trial approval or funding pathway

      • The study or investigation is approved or funded by NIH, CDC, AHRQ, CMS, a qualifying cooperative group or center, a qualified nongovernmental research entity, DOD, VA, or DOE under the applicable peer-review conditions.
      • The study or investigation is conducted under an FDA-reviewed investigational new drug application or is a drug trial exempt from that application.
    • Participant appropriateness

    Oregon members

    Oregon routine clinical trial costs are covered when all of the following conditions are met.

    Oregon routine patient care coverage

    • The member is enrolled in or participating in a qualifying clinical trial.
    • The service is medically necessary conventional care, an item, or a service that the plan would typically cover if provided outside the clinical trial, such as hospital care, laboratory tests, or imaging.
    • Applicable cost sharing is imposed as if the service were provided outside the clinical trial.
    • Routine costs for treatment of adverse effects of the clinical trial are covered.

    Alaska members

    Alaska routine and additional trial-related costs are covered when all of the following conditions are met.

    Alaska routine and additional costs

    • The member is enrolled in an approved clinical trial under federal or state law related to cancer or another life-threatening disease or condition.
    • The treating physicians determine that there is no clear superior non-investigational treatment alternative.
    • Available clinical or preclinical data provide a reasonable expectation that the trial treatment will be at least as efficacious as any non-investigational alternative.
    • Covered costs are subject to applicable cost sharing as if provided outside a clinical trial.
    • Routine costs for treatment of adverse effects of the clinical trial are covered.

    Texas members

    Texas routine patient care costs are covered when all of the following conditions are met.

    Texas routine patient care

    • The request is connected with a Phase I, II, III, or IV clinical trial.Phase I-IV
    • The clinical trial is conducted for prevention, detection, or treatment of a life-threatening disease or condition.
    • The member is enrolled in a qualified clinical trial.
    • When reimbursement is sought through the research institution, the institution and each health care professional providing routine patient care through it agree to accept the plan's established rates as payment in full.

    Idaho members

    Idaho routine patient care costs are covered when all of the following conditions are met.

    Idaho routine patient care

    • The service is a medically necessary health care service for which benefits are provided under the health benefit plan without regard to clinical-trial participation.
    • The member is enrolled in an approved Phase I, II, III, or IV clinical trial.Phase I-IV
    • The clinical trial concerns prevention, detection, or treatment of a disease or condition.

    Washington members

    Washington routine patient care costs are covered when all of the following conditions are met, subject to applicable plan limitations and requirements.

    Washington routine patient care

    • The item or service is consistent with and typically covered by the plan for an enrollee who is not participating in a clinical trial.
    • The enrollee meets the clinical-trial eligibility requirements according to the trial protocol when required.
    • The item or service is used in the direct clinical management of the enrollee and not solely to satisfy research data collection or analysis needs.

    Medicare Part B clinical-trial coverage

    For Medicare Part B services, coverage is subject to applicable CMS requirements.

    Applicable Medicare coverage requirements

    • Comply with applicable Medicare Benefit Policy Manual provisions, National Coverage Determinations, and Local Coverage Determinations, including NCD 310.1 for routine costs in clinical trials where applicable.

    For Oregon members, the investigational drug, device, or service is not covered unless the Moda Health plan would cover it when provided outside a clinical trial. Coverage also excludes items or services required solely to provide or clinically monitor the investigational intervention, services used solely for research data collection or analysis and not for direct clinical management, items or services customarily provided free of charge by the trial sponsor, and services not covered outside the trial.

    For Alaska members, coverage excludes a drug or device associated with the trial that has not been approved by the FDA, including an unapproved indication, dose, frequency of administration, or combination therapy. Excluded costs also include housing, companion expenses, other non-clinical expenses, research-only data collection or analysis, items or services excluded under the member handbook, and items or services paid or customarily paid through grants or other funding.

    Where applicable, the investigational item, device, or service itself is not covered. Routine patient care costs also exclude research-only services used solely for data collection or analysis, non-health-care services, clinical trial management costs, services specifically excluded under the member's health plan, and services customarily paid by the research institution.

    A service that is clearly inconsistent with widely accepted and established standards of care for the member's particular diagnosis is not covered. This limitation applies to clinical-trial services and routine patient care costs where specified by the applicable state or federal coverage requirements.

    Clinical Trial Coding

    Covered HCPCS CodesHCPCSCovered
    G0293Noncovered surgical procedure(s) using conscious sedation, regional, general, or spinal anesthesia in a Medicare-qualifying clinical trial, per day.
    G0294Noncovered surgical procedure(s) using either no anesthesia or local anesthesia only, in a Medicare qualifying clinical trial, per day.
    S9988Services provided as a part of a phase I clinical trial.
    S9990Services provided as a part of a phase II clinical trial.
    S9991Services provided as a part of a phase III clinical trial.
    Covered Clinical-Trial ModifiersModifierCovered
    Q0Investigational clinical service provided in a clinical research study that is in an approved clinical research study.
    Q1Routine clinical service provided in a clinical research study that is in an approved clinical research study.
    Covered ICD-10 Diagnosis CodesICD-10Covered
    Z00.6Encounter for examination for normal comparison and control in clinical research program

    Authorization, Documentation, and Coverage Actions

    Prior Authorization

    Clinical Trial Prior Authorization Required

    Obtain prior authorization before providing or billing services associated with a clinical trial. Submit the clinical-trial request with the required clinical, protocol, consent, and IRB documentation for Moda Health review.

    • Submit the prior authorization request before trial-related care is initiated.
    • Include all records listed in “Required Prior Authorization Records.”
    Documentation Required

    Required Prior Authorization Records

    Include sufficient records to establish the member’s diagnosis, treatment history, eligibility, and appropriateness for the requested trial.

    • History and physical.
    • Treatment history for the condition for which the trial is requested.

    Clinical Trial Coverage Background

    Clinical trials are protocol-driven research studies that evaluate the safety and effectiveness of new treatments, drugs, devices, diagnostic tests, or screenings. They may be conducted in Phase I through Phase IV and generally involve both patient-care costs and research costs.

    This policy primarily addresses coverage of routine or usual care costs—medically necessary conventional care, items, or services that Moda Health would typically cover outside a clinical trial, such as hospital care, laboratory tests, and imaging. Costs associated with conducting the trial, including data collection and management, research staff time, analysis of results, and tests performed solely for research, are generally the responsibility of the sponsor or research institution. Coverage requirements and exclusions vary by member state, and qualified clinical-trial requests require prior authorization and supporting documentation.

    Clinical Trial Terms and Cost Definitions

    Clinical trial
    DefinitionA research study that evaluates the safety and effectiveness of new medical treatments, drugs, diagnostic tests, or screenings.
    ComparisonThe study compares a new, untested, or non-standard treatment with standard treatments accepted and used in the medical community.
    ProtocolClinical trials follow a protocol describing participation requirements, study length, testing schedules, procedures, and medications.
    Phase I
    Study populationA small group of people receiving a new drug or treatment for the first time.
    Primary purposeTo evaluate safety and determine a safe dosage range.
    Policy Summary
    PayerModa Health
    PolicyClinical Trials
    Policy CodePolicy N/A
    Change TypeModified
    Effective DateOct 1, 2026
    Last ReviewSep 23, 2026
    Next Review DateN/A
    Key ActionSubmit prior authorization with the patient's history and physical, treatment history, detailed protocol, signed informed consent, and IRB approval.
    SourceLink
    On This Page
    Qualified Clinical Trial Coverage CriteriaClinical Trial CodingAuthorization, Documentation, and Coverage ActionsClinical Trial Coverage BackgroundClinical Trial Terms and Cost Definitions
  1. The individual is eligible to participate in the approved clinical trial according to the trial protocol for treatment of cancer or another life-threatening disease or condition.
  2. Appropriateness pathway

    • The referring health care professional is a participating provider and has concluded that participation is appropriate based on the individual's eligibility.
    • The participant or beneficiary provides medical and scientific information establishing that participation is appropriate based on the individual's eligibility.
  3. Additional covered costs may include prevention, diagnosis, treatment, and palliative care for the qualified condition; otherwise-covered medical care connected with the trial; items or services necessary to provide an investigational item or service; diagnosis or treatment of complications; FDA-approved drugs or devices not paid for by the manufacturer, distributor, or provider; services necessary to administer a trial drug or device; and transportation primarily for and essential to the member's medical care.
  4. Detailed clinical trial protocol.
  5. Patient-signed informed consent document.
  6. Institutional Review Board (IRB) approval.
  7. Documentation that the individual meets the trial protocol’s eligibility requirements.
  8. Documentation that participation is appropriate from the referring participating provider or medical and scientific information supporting appropriateness.
  9. Unsupported block type: denial_risk

    Denial Risk

    Excluded Trial-Related Costs

    Do not bill Moda Health for the investigational item, device, or service itself or for research-related services that are not routine medically necessary care. Apply the member’s benefit exclusions and the applicable state-specific limitations.

    • The tested drug, device, or service is excluded unless it would be covered outside the trial.
    • Exclude items or services required solely to provide or monitor the investigational intervention.
    • Exclude services provided solely for data collection or analysis that are not used in direct clinical management.
    • Exclude services inconsistent with widely accepted and established standards of care, non-health-care services, trial-management costs, and services excluded under the member’s plan.
    • Exclude items or services customarily provided or paid for by the sponsor, research institution, grants, or other funding.
    • Exclude housing, companion expenses, and other non-clinical trial expenses.
    • For Alaska members, exclude an unapproved FDA drug or device associated with the trial, including an unapproved indication, dose, frequency, or combination therapy.
    • For Texas members, reimbursement to the research institution requires the institution and each participating health care professional to accept plan rates as payment in full; services customarily paid by the research institution are not required benefits.
    Documentation Required

    Alaska Clinical Appropriateness

    For Alaska members, confirm that the trial is approved under applicable federal or state law and relates to cancer or another life-threatening condition. Coverage requires the treating physicians to determine that no clear superior non-investigational alternative exists and that available data reasonably support efficacy at least comparable to a non-investigational alternative.

    • Apply applicable member cost sharing as if care were provided outside a clinical trial.
    • Routine costs for treatment of clinical-trial adverse effects are covered when otherwise eligible.
    • Document the treating physicians’ alternative-treatment determination and the supporting clinical or preclinical evidence.
    Billing Rule

    Texas Trial and Reimbursement Requirements

    For Texas members, verify that the request concerns a Phase I, II, III, or IV trial for prevention, detection, or treatment of a life-threatening disease or condition. Reimbursement is subject to the plan-rate and research-institution requirements.

    • Routine care does not include an investigational new drug or device not FDA-approved for any indication.
    • Exclude non-health-care services, services inconsistent with established standards of care, trial-management costs, and services excluded by the health plan.
    • The research institution and each health care professional providing routine care through it must accept plan-established rates as payment in full.

    Unsupported block type: billing_rule

    Additional purposeTo identify side effects associated with the new drug or treatment.
    Phase II
    Study populationA larger group of people receives the drug or treatment.
    Primary purposeTo evaluate whether the drug or treatment is effective.
    Additional purposeTo further evaluate its safety.
    Phase III
    Study populationA larger group of people receives the drug or treatment.
    Primary purposeTo confirm effectiveness and monitor side effects.
    Comparison and safety informationThe study compares the intervention with commonly used treatments and collects information needed for safe use.
    Phase IV
    TimingA post-marketing study performed after the drug or treatment has been marketed.
    Primary purposeTo gather information about effects in various populations.
    Long-term safetyThe study gathers information about side effects associated with long-term use.
    Routine or usual care costs
    DefinitionMedically necessary conventional care, items, or services that the health plan would typically cover if provided outside a clinical trial.
    ExamplesExamples include doctor visits, hospital care or stays, clinical laboratory tests, x-rays, and imaging.
    Coverage basisThese costs occur whether the patient participates in a clinical trial or receives standard treatment and are subject to applicable plan coverage and cost sharing.
    Research costs
    DefinitionCosts associated with conducting the clinical trial.
    Included costsResearch costs include data collection and management, research physician and nurse time, and analysis of results.
    Research-only servicesThey include tests performed purely for research purposes.
    Typical payerResearch costs are usually covered by the organization sponsoring the clinical trial; costs for studied drugs or devices may also be covered by the sponsor.